Compounds > 1,4-phenylenebis(methylene)selenocyanate
Page last updated: 2024-11-05

1,4-phenylenebis(methylene)selenocyanate and Prostatic Neoplasms

1,4-phenylenebis(methylene)selenocyanate has been researched along with Prostatic Neoplasms in 2 studies

1,4-phenylenebis(methylene)selenocyanate: structure given in first source; inhibits DMBA-induced carcinogenesis by inhibiting DMBA-DNA adduct formation

Prostatic Neoplasms: Tumors or cancer of the PROSTATE.

Research Excerpts

ExcerptRelevanceReference
"The long latency of prostate cancer development provides an opportunity to intervene with agents of known mechanisms at various stages of disease progression."1.361,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells. ( El-Bayoumy, K; Facompre, ND; Pinto, JT; Sinha, R; Sun, YW, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Facompre, ND2
El-Bayoumy, K2
Sun, YW1
Pinto, JT2
Sinha, R2
Sinha, I1

Other Studies

2 other studies available for 1,4-phenylenebis(methylene)selenocyanate and Prostatic Neoplasms

ArticleYear
1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.
    Cancer prevention research (Philadelphia, Pa.), 2010, Volume: 3, Issue:8

    Topics: Androgen Antagonists; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Evaluation, Preclin

2010
Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.
    International journal of cancer, 2012, Nov-01, Volume: 131, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carrier Proteins; Cell Line, Tumor; Cell Proliferati

2012